Amalgamated Research

Amalgamated Research

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Amalgamated Research LLC (ARi) is a private, established player in industrial process technology, focusing on separation and fluid handling. Its proprietary, patented fractal distribution and mixing technology serves as a functional alternative to turbulence, offering clients significant improvements in efficiency and energy use. The company operates a full-service model, from lab-scale testing and pilot programs to full-scale industrial installation, serving global markets in food, sweeteners, renewables, biofuels, and mining. ARi is a revenue-generating engineering and services firm, not a therapeutic biotech, with its 'pipeline' consisting of new industrial applications for its core platform.

Drug Delivery

Technology Platform

Patented fractal fluid control technology for high-efficiency industrial distribution, mixing, and separation. This platform underpins their chromatography and ion exchange systems, offering reduced energy use and improved scale-up accuracy compared to conventional turbulent methods.

Opportunities

Major growth is driven by the Direct Lithium Extraction (DLE) market for EV batteries and the expanding bio-based economy requiring efficient separation in biorefineries.
Global trends towards industrial efficiency and sustainability further amplify demand for their energy-saving fractal technology.

Risk Factors

Revenue is subject to capital expenditure cycles in its core industries like sugar and mining.
The company faces competition from established engineering firms and must continuously convince conservative industries to adopt its proprietary fractal design paradigm over conventional systems.

Competitive Landscape

ARi competes with other specialized engineering firms and large industrial equipment providers that offer chromatography and ion exchange systems (e.g., Pall, GE Healthcare Life Sciences [now Cytiva] in bioprocessing, and other SMB chromatography providers). Its key differentiator is its patented fractal technology, which claims superior efficiency and energy savings, creating a niche in process-intensification and sustainable design.